Saved in:
| Main Authors: | Jaehyun Seo, Chanmin Kim |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1002/sim.10028 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Multivariate probit linear mixed models for multivariate longitudinal binary data
by: Kuo‐Jung Lee, et al.
Published: (2024)
by: Kuo‐Jung Lee, et al.
Published: (2024)
Bayesian Variable Selection for High‐Dimensional Mediation Analysis: Application to Metabolomics Data in Epidemiological Studies
by: Youngho Bae, et al.
Published: (2026)
by: Youngho Bae, et al.
Published: (2026)
Group sequential designs for clinical trials when the maximum sample size is uncertain
by: Amin Yarahmadi, et al.
Published: (2024)
by: Amin Yarahmadi, et al.
Published: (2024)
Assurance methods for designing a clinical trial with a delayed treatment effect
by: James A. Salsbury, et al.
Published: (2024)
by: James A. Salsbury, et al.
Published: (2024)
Robust analysis of stepped wedge trials using composite likelihood models
by: Emily C. Voldal, et al.
Published: (2024)
by: Emily C. Voldal, et al.
Published: (2024)
Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
by: Yunfei Wang
Published: (2024)
by: Yunfei Wang
Published: (2024)
Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
by: Wenhao Cao, et al.
Published: (2024)
by: Wenhao Cao, et al.
Published: (2024)
A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
by: Tianyu Zhan
Published: (2024)
by: Tianyu Zhan
Published: (2024)
Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
by: Luana Boumendil, et al.
Published: (2024)
by: Luana Boumendil, et al.
Published: (2024)
Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
by: Jialu Fang, et al.
Published: (2024)
by: Jialu Fang, et al.
Published: (2024)
Approximate maximum likelihood estimation in cure models using aggregated data, with application to HPV vaccine completion
by: John D. Rice, et al.
Published: (2024)
by: John D. Rice, et al.
Published: (2024)
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
by: Johannes Krisam, et al.
Published: (2024)
by: Johannes Krisam, et al.
Published: (2024)
Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
by: Peiran Liu, et al.
Published: (2024)
by: Peiran Liu, et al.
Published: (2024)
Confidence sets for a level set in linear regression
by: Fang Wan, et al.
Published: (2024)
by: Fang Wan, et al.
Published: (2024)
Modeling multiple‐criterion diagnoses by heterogeneous‐instance logistic regression
by: Chun‐Hao Yang, et al.
Published: (2024)
by: Chun‐Hao Yang, et al.
Published: (2024)
Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy
by: Tali Faggiano, et al.
Published: (2025)
by: Tali Faggiano, et al.
Published: (2025)
τ$$ \tau $$‐Inflated beta regression model for censored recurrent events
by: Yizhuo Wang, et al.
Published: (2024)
by: Yizhuo Wang, et al.
Published: (2024)
Penalized weighted smoothed quantile regression for high‐dimensional longitudinal data
by: Yanan Song, et al.
Published: (2024)
by: Yanan Song, et al.
Published: (2024)
Use of win time for ordered composite endpoints in clinical trials
by: James F. Troendle, et al.
Published: (2024)
by: James F. Troendle, et al.
Published: (2024)
Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment
by: D. Dulana C. Suriyarachchi, et al.
Published: (2025)
by: D. Dulana C. Suriyarachchi, et al.
Published: (2025)
Weighting estimation in the cause‐specific Cox regression with partially missing causes of failure
by: Jooyoung Lee, et al.
Published: (2024)
by: Jooyoung Lee, et al.
Published: (2024)
Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
by: Fei Gao, et al.
Published: (2025)
by: Fei Gao, et al.
Published: (2025)
A Bayesian semi‐parametric scalar‐on‐function regression with measurement error using instrumental variables
by: Roger S Zoh, et al.
Published: (2024)
by: Roger S Zoh, et al.
Published: (2024)
The role of an artificial intelligence model in antiretroviral therapy counselling and advice for people living with HIV
by: Matthew Chung Yi Koh, et al.
Published: (2024)
by: Matthew Chung Yi Koh, et al.
Published: (2024)
Approximate balancing weights for clustered observational study designs
by: Eli Ben‐Michael, et al.
Published: (2024)
by: Eli Ben‐Michael, et al.
Published: (2024)
Comparing methods for assessing the reliability of health care quality measures
by: Kenneth J. Nieser, et al.
Published: (2024)
by: Kenneth J. Nieser, et al.
Published: (2024)
Correction to “Using principal stratification in analysis of clinical trials”
by: Ilya Lipkovich, et al.
Published: (2024)
by: Ilya Lipkovich, et al.
Published: (2024)
Using a monotonic density ratio model to increase the power of the goodness‐of‐fit test for logistic regression models with case‐control data
by: Chunlin Wang, et al.
Published: (2024)
by: Chunlin Wang, et al.
Published: (2024)
Multilevel Regression and Poststratification Using Margins of Poststratifiers: Improving Inference for HIV Health Outcomes During the COVID‐19 Pandemic
by: Amy J. Pitts, et al.
Published: (2025)
by: Amy J. Pitts, et al.
Published: (2025)
Confidence distributions for treatment effects in clinical trials: Posteriors without priors
by: Ian C. Marschner
Published: (2024)
by: Ian C. Marschner
Published: (2024)
Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
by: Shuxi Zeng, et al.
Published: (2024)
by: Shuxi Zeng, et al.
Published: (2024)
A sequential, multiple assignment, randomized trial design with a tailoring function
by: Holly Hartman, et al.
Published: (2024)
by: Holly Hartman, et al.
Published: (2024)
Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers
by: Yanping Chen, et al.
Published: (2024)
by: Yanping Chen, et al.
Published: (2024)
Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
by: Ethan Ashby, et al.
Published: (2025)
by: Ethan Ashby, et al.
Published: (2025)
Data fusion for predicting long‐term program impacts
by: Michael W. Robbins, et al.
Published: (2024)
by: Michael W. Robbins, et al.
Published: (2024)
A Bayesian non‐stationary heteroskedastic time series model for multivariate critical care data
by: Zayd Omar, et al.
Published: (2024)
by: Zayd Omar, et al.
Published: (2024)
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
by: Yu Du, et al.
Published: (2024)
by: Yu Du, et al.
Published: (2024)
A comparison of hyperparameter tuning procedures for clinical prediction models: A simulation study
by: Zoë S. Dunias, et al.
Published: (2024)
by: Zoë S. Dunias, et al.
Published: (2024)
A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
by: Stephen Schüürhuis, et al.
Published: (2024)
by: Stephen Schüürhuis, et al.
Published: (2024)
Dual drivers of polypharmacy in people with HIV : Quantifying the independent associations of aging and long‐term antiretroviral therapy
by: Shigeru Hasebe, et al.
Published: (2025)
by: Shigeru Hasebe, et al.
Published: (2025)
Similar Items
-
Multivariate probit linear mixed models for multivariate longitudinal binary data
by: Kuo‐Jung Lee, et al.
Published: (2024) -
Bayesian Variable Selection for High‐Dimensional Mediation Analysis: Application to Metabolomics Data in Epidemiological Studies
by: Youngho Bae, et al.
Published: (2026) -
Group sequential designs for clinical trials when the maximum sample size is uncertain
by: Amin Yarahmadi, et al.
Published: (2024) -
Assurance methods for designing a clinical trial with a delayed treatment effect
by: James A. Salsbury, et al.
Published: (2024) -
Robust analysis of stepped wedge trials using composite likelihood models
by: Emily C. Voldal, et al.
Published: (2024)